- Home
- CVGI vs INKT Comparison
CVGI vs INKT Comparison
Compare CVGI & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- INKT
- Stock Information
- Founded
- CVGI 2000
- INKT 2017
- Country
- CVGI United States
- INKT United States
- Employees
- CVGI N/A
- INKT N/A
- Industry
- CVGI Auto Parts:O.E.M.
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CVGI Consumer Discretionary
- INKT Health Care
- Exchange
- CVGI Nasdaq
- INKT Nasdaq
- Market Cap
- CVGI 34.0M
- INKT 28.9M
- IPO Year
- CVGI 2004
- INKT 2021
- Fundamental
- Price
- CVGI $1.31
- INKT $7.25
- Analyst Decision
- CVGI Buy
- INKT Strong Buy
- Analyst Count
- CVGI 1
- INKT 2
- Target Price
- CVGI $10.00
- INKT $37.50
- AVG Volume (30 Days)
- CVGI 275.5K
- INKT 3.0K
- Earning Date
- CVGI 08-04-2025
- INKT 08-12-2025
- Dividend Yield
- CVGI N/A
- INKT N/A
- EPS Growth
- CVGI N/A
- INKT N/A
- EPS
- CVGI N/A
- INKT N/A
- Revenue
- CVGI $698,524,000.00
- INKT N/A
- Revenue This Year
- CVGI N/A
- INKT N/A
- Revenue Next Year
- CVGI $7.37
- INKT N/A
- P/E Ratio
- CVGI N/A
- INKT N/A
- Revenue Growth
- CVGI N/A
- INKT N/A
- 52 Week Low
- CVGI $0.81
- INKT $4.56
- 52 Week High
- CVGI $5.69
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- CVGI 49.63
- INKT 47.35
- Support Level
- CVGI $1.31
- INKT $7.20
- Resistance Level
- CVGI $1.41
- INKT $7.57
- Average True Range (ATR)
- CVGI 0.10
- INKT 0.17
- MACD
- CVGI -0.02
- INKT 0.03
- Stochastic Oscillator
- CVGI 21.21
- INKT 44.07
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.